239 related articles for article (PubMed ID: 12891954)
21. Retrospective analysis of the effects of ritodrine and terbutaline in the management of preterm labor.
Weiss MA
Clin Pharm; 1982; 1(5):453-6. PubMed ID: 7184677
[TBL] [Abstract][Full Text] [Related]
22. Antibiotic administration to patients with preterm labor and intact membranes: is there a beneficial effect in patients with endocervical inflammation?
Ovalle A; Romero R; Gómez R; Martínez MA; Nien JK; Ferrand P; Aspillaga C; Figueroa J
J Matern Fetal Neonatal Med; 2006 Aug; 19(8):453-64. PubMed ID: 16966109
[TBL] [Abstract][Full Text] [Related]
23. The cost effectiveness of stopping preterm labor with beta-adrenergic treatment.
Korenbrot CC; Aalto LH; Laros RK
N Engl J Med; 1984 Mar; 310(11):691-6. PubMed ID: 6142417
[TBL] [Abstract][Full Text] [Related]
24. Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?
How HY; Barton JR; Istwan NB; Rhea DJ; Stanziano GJ
Am J Obstet Gynecol; 2007 Sep; 197(3):260.e1-4. PubMed ID: 17826411
[TBL] [Abstract][Full Text] [Related]
25. Oral nifedipine maintenance therapy after acute intravenous tocolysis in preterm labor.
Sayin NC; Varol FG; Balkanli-Kaplan P; Sayin M
J Perinat Med; 2004; 32(3):220-4. PubMed ID: 15188794
[TBL] [Abstract][Full Text] [Related]
26. Women receiving 17-alpha-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance.
Rittenberg C; Sullivan S; Istwan N; Rhea D; Stanziano G; Newman R
Am J Obstet Gynecol; 2008 Oct; 199(4):389.e1-4. PubMed ID: 18928983
[TBL] [Abstract][Full Text] [Related]
27. Clinical issues surrounding the use of terbutaline sulfate for preterm labor.
Lam F; Elliott J; Jones JS; Katz M; Knuppel RA; Morrison J; Newman R; Phelan J; Willcourt R
Obstet Gynecol Surv; 1998 Nov; 53(11 Suppl):S85-95. PubMed ID: 9812326
[TBL] [Abstract][Full Text] [Related]
28. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial.
Lyell DJ; Pullen K; Campbell L; Ching S; Druzin ML; Chitkara U; Burrs D; Caughey AB; El-Sayed YY
Obstet Gynecol; 2007 Jul; 110(1):61-7. PubMed ID: 17601897
[TBL] [Abstract][Full Text] [Related]
29. The treatment of preterm labor using a portable subcutaneous terbutaline pump.
Sala DJ; Moise KJ
J Obstet Gynecol Neonatal Nurs; 1990; 19(2):108-15. PubMed ID: 2319362
[TBL] [Abstract][Full Text] [Related]
30. Terbutaline versus nifedipine for prolongation of pregnancy in patients with preterm labor.
Mawaldi L; Duminy P; Tamim H
Int J Gynaecol Obstet; 2008 Jan; 100(1):65-8. PubMed ID: 17894937
[TBL] [Abstract][Full Text] [Related]
31. Subcutaneous tocolytic infusion therapy for patients at very high risk for preterm birth.
Allbert JR; Wise CA; Lou CH; Gookin KS; Parmenter MA; Morrison JC
J Perinatol; 1992 Mar; 12(1):28-31. PubMed ID: 1348530
[TBL] [Abstract][Full Text] [Related]
32. The clinical efficacy of oral tocolytic therapy.
Rust OA; Bofill JA; Arriola RM; Andrew ME; Morrison JC
Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):838-42. PubMed ID: 8885732
[TBL] [Abstract][Full Text] [Related]
33. Use of the subcutaneous terbutaline pump for long-term tocolysis.
Lam F; Gill P; Smith M; Kitzmiller JL; Katz M
Obstet Gynecol; 1988 Nov; 72(5):810-3. PubMed ID: 3173932
[TBL] [Abstract][Full Text] [Related]
34. Treatment of premature labor with subcutaneous terbutaline.
Stubblefield PG; Heyl PS
Obstet Gynecol; 1982 Apr; 59(4):457-62. PubMed ID: 7078898
[TBL] [Abstract][Full Text] [Related]
35. [Continuous subcutaneous administration of terbutaline in the therapy of threatening premature labour].
Pomini F; De Carolis S; Ferrazzani S; De Santis L; Carducci B; Caruso A
Minerva Ginecol; 1993; 45(1-2):57-63. PubMed ID: 8469366
[TBL] [Abstract][Full Text] [Related]
36. Celecoxib versus magnesium sulfate to arrest preterm labor: randomized trial.
Borna S; Saeidi FM
J Obstet Gynaecol Res; 2007 Oct; 33(5):631-4. PubMed ID: 17845320
[TBL] [Abstract][Full Text] [Related]
37. 17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis.
Odibo AO; Stamilio DM; Macones GA; Polsky D
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):492-9. PubMed ID: 16946206
[TBL] [Abstract][Full Text] [Related]
38. Tocolytic therapy and clinical experience. Combination therapy.
Ingemarsson I
BJOG; 2005 Mar; 112 Suppl 1():89-93. PubMed ID: 15715603
[TBL] [Abstract][Full Text] [Related]
39. Telemedicine: cost-effective management of high-risk pregnancy.
Morrison J; Bergauer NK; Jacques D; Coleman SK; Stanziano GJ
Manag Care; 2001 Nov; 10(11):42-6, 48-9. PubMed ID: 11761593
[TBL] [Abstract][Full Text] [Related]
40. Terbutaline pump maintenance therapy for prevention of preterm delivery: a double-blind trial.
Guinn DA; Goepfert AR; Owen J; Wenstrom KD; Hauth JC
Am J Obstet Gynecol; 1998 Oct; 179(4):874-8. PubMed ID: 9790362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
